2025-02-27
Recently, six new projects from KHB Reference Laboratory successfully passed the rigorous evaluation by the Joint Committee for Traceability in Laboratory Medicine (JCTLM). With the addition of these six projects to the five already included, KHB now boasts a total of 11 projects on the JCTLM Medical Reference Measurement List, enabling the company to offer advanced measurement traceability services to healthcare providers worldwide.
In 2022, KHB’s Reference Laboratory achieved accreditation from the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) JCTLM. This accreditation underscores the "international comparability" and "global credibility" of the laboratory’s test results, allowing the laboratory to provide more precise and reliable support for clinical diagnostics, standard substance value assignment, disease monitoring, and scientific research.
The 11 JCTLM-certified projects span key testing areas such as metabolism, liver and kidney function, and enzymology, including:
√ Metabolism: Glucose, Urea, Total Cholesterol (TC)
√ Liver & Kidney Function: Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Creatinine
√ Enzymology: Alkaline Phosphatase (ALP), Amylase (AMY), Creatine Kinase (CK), Lactate Dehydrogenase (LDH), Gamma-Glutamyl Transferase (GGT)
JCTLM Certification: A Gold Standard in Measurement Traceability
Measurement traceability is considered the cornerstone of standardizing and harmonizing medical test results. The Joint Committee for Traceability in Laboratory Medicine (JCTLM) is one of the world’s leading certification bodies for measurement traceability in laboratory medicine. For Chinese companies to pursue JCTLM certification, they must first obtain accreditation from the China National Accreditation Service for Conformity Assessment (CNAS), which ensures that only those with the highest technical standards can be considered. Therefore, JCTLM certification represents the pinnacle of international laboratory medicine.
About KHB Reference Laboratory
Founded in 2010, KHB’s Reference Laboratory has long been committed to driving industry standardization and regulation. Over the years, the laboratory has actively contributed to the development and joint value assignment of international and national standard substances, covering projects in areas such as enzymology, metabolites and substrates, non-peptide hormones, proteins, and vitamins.
In 2020, the laboratory received CNAS Reference Laboratory accreditation for 18 projects. Since then, it has accumulated 11 JCTLM certifications as of 2022. The results of these accredited projects directly benefit global medical institutions, standard substance manufacturers, and research organizations, providing critical data for early disease detection, treatment optimization, and drug development. These achievements not only signify international recognition of the laboratory’s technical expertise but also highlight our unwavering commitment to high standards of accuracy, reliability, excellence, and risk control.
KHB continues to leverage its world-class measurement traceability system to ensure the accuracy and reliability of every batch of products. Looking ahead, the company will maintain its core values of "Care for life, Dedicate to excellence" further solidifying its position as a leader in establishing internationally recognized reference methods, enhancing its technical capabilities, expanding testing services, and delivering superior diagnostic products and services to customers around the globe.